{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T17:15:03Z","timestamp":1773767703593,"version":"3.50.1"},"reference-count":69,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Swedish Foundation for Humanities and Social Sciences","award":["M13\u20130260:1"],"award-info":[{"award-number":["M13\u20130260:1"]}]},{"DOI":"10.13039\/100014461","name":"NIHR Birmingham Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014461","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000142","name":"The Arthritis Society","doi-asserted-by":"publisher","award":["YIS-16-104"],"award-info":[{"award-number":["YIS-16-104"]}],"id":[{"id":"10.13039\/501100000142","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000245","name":"Michael Smith Foundation for Health Research","doi-asserted-by":"publisher","award":["16813"],"award-info":[{"award-number":["16813"]}],"id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.clinthera.2019.04.015","type":"journal-article","created":{"date-parts":[[2019,6,9]],"date-time":"2019-06-09T23:59:02Z","timestamp":1560124742000},"page":"1346-1354","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Preferences of Patients and At-risk Individuals for Preventive Approaches to Rheumatoid Arthritis"],"prefix":"10.1016","volume":"41","author":[{"given":"Marie","family":"Falahee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Finckh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karim","family":"Raza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2019.04.015_bib1","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1002\/art.27692","article-title":"Long-term impact of delay in assessment of patients with early arthritis","volume":"62","author":"van der Linden","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2019.04.015_bib2","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/annrheumdis-2016-210715","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update","volume":"76","author":"Smolen","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2019.04.015_bib3","series-title":"Economic Burden of RA Report","year":"2010"},{"key":"10.1016\/j.clinthera.2019.04.015_bib4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1185\/03007990903422307","article-title":"Societal cost of rheumatoid arthritis patients in the US","volume":"26","author":"Birnbaum","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.clinthera.2019.04.015_bib5","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.rdc.2014.07.001","article-title":"Preclinical inflammatory rheumatic diseases: an overview and relevant nomenclature","volume":"40","author":"Raza","year":"2014","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.clinthera.2019.04.015_bib6","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1136\/annrheumdis-2016-209846","article-title":"EULAR definition of arthralgia suspicious for progression to rheumatoid arthritis","volume":"76","author":"van Steenbergen","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2019.04.015_bib7","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/annrheumdis-2011-200990","article-title":"EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis","volume":"71","author":"Gerlag","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2019.04.015_bib8","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1136\/annrheumdis-2012-202127","article-title":"A\u00a0prediction rule for the development of arthritis in seropositive arthralgia patients","volume":"72","author":"van de Stadt","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2019.04.015_bib9","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1002\/art.23681","article-title":"Validation of a prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: moving toward individualized treatment decision-making","volume":"58","author":"van der Helm-van Mil","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2019.04.015_bib10","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1136\/annrheumdis-2012-202753","article-title":"The type I IFN signature as a biomarker of preclinical rheumatoid arthritis","volume":"72","author":"Lubbers","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2019.04.015_bib11","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1136\/annrheumdis-2015-207324","article-title":"B\u00a0cell signature contributes to the prediction of RA development in patients with arthralgia","volume":"74","author":"Lubbers","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2019.04.015_bib12","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1136\/annrheumdis-2017-211351","article-title":"Dominant B cell receptor clones in peripheral blood predict onset of arthritis in individuals at risk for rheumatoid arthritis","volume":"76","author":"Tak","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2019.04.015_bib13","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s13075-017-1405-y","article-title":"Absence of ultrasound inflammation in patients presenting with arthralgia rules out the development of arthritis","volume":"19","author":"van der Ven","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.clinthera.2019.04.015_bib14","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1136\/ard.2010.131573","article-title":"Utility of ultrasound joint counts in the prediction of rheumatoid arthritis in patients with very early synovitis","volume":"70","author":"Filer","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.clinthera.2019.04.015_bib15","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1093\/rheumatology\/key025","article-title":"The role of ultrasound-defined tenosynovitis and synovitis in the prediction of rheumatoid arthritis development","volume":"57","author":"Sahbudin","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clinthera.2019.04.015_bib16","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1002\/art.24833","article-title":"A\u00a0prospective approach to investigating the natural history of preclinical rheumatoid arthritis (RA) using first-degree relatives of probands with RA","volume":"61","author":"Kolfenbach","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2019.04.015_bib17","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.berh.2017.08.005","article-title":"Emerging therapies for pre-RA","volume":"31","author":"Cope","year":"2017","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.clinthera.2019.04.015_bib18","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1136\/ard.2009.120899","article-title":"Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke","volume":"70","author":"Kallberg","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2019.04.015_bib19","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/rheumatology\/keu287","article-title":"Strategies to predict rheumatoid arthritis development in at-risk populations","volume":"55","author":"Karlson","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clinthera.2019.04.015_bib20","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/ard.2008.105767","article-title":"Effect of dexamethasone on autoantibody levels and arthritis development in patients with arthralgia: a randomised trial","volume":"69","author":"Bos","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2019.04.015_bib21","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1136\/ard.2009.119149","article-title":"Beneficial effects of a 3-week course of intramuscular glucocorticoid injections in patients with very early inflammatory polyarthritis: results of the STIVEA trial","volume":"69","author":"Verstappen","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2019.04.015_bib22","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/annrheumdis-2017-212763","article-title":"Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis: the PRAIRI study","volume":"78","author":"Gerlag","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2019.04.015_bib23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1539-6053.2008.00033.x","article-title":"Helping doctors and patients make sense of health statistics","volume":"8","author":"Gigerenzer","year":"2007","journal-title":"Psychol Sci Public Interest"},{"key":"10.1016\/j.clinthera.2019.04.015_bib24","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10897-008-9210-z","article-title":"A\u00a0systematic review of the impact of genetic counseling on risk perception accuracy","volume":"18","author":"Smerecnik","year":"2009","journal-title":"J\u00a0Genet Couns"},{"key":"10.1016\/j.clinthera.2019.04.015_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000134","article-title":"The effect of alternative summary statistics for communicating risk reduction on decisions about taking statins: a randomized trial","volume":"6","author":"Carling","year":"2009","journal-title":"Plos Med"},{"key":"10.1016\/j.clinthera.2019.04.015_bib26","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1177\/0272989X10391672","article-title":"Informing patients: the influence of numeracy, framing, and format of side effect information on risk perceptions","volume":"31","author":"Peters","year":"2011","journal-title":"Med Decis Making"},{"key":"10.1016\/j.clinthera.2019.04.015_bib27","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1037\/a0013608","article-title":"Explanations for side effect aversion in preventive medical treatment decisions","volume":"28","author":"Waters","year":"2009","journal-title":"Health Psychol"},{"key":"10.1016\/j.clinthera.2019.04.015_bib28","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1200\/JCO.2009.27.8077","article-title":"Patient decisions about breast cancer chemoprevention: a systematic review and meta-analysis","volume":"28","author":"Ropka","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clinthera.2019.04.015_bib29","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e3953","article-title":"Lay perspectives on hypertension and drug adherence: systematic review of qualitative research","volume":"345","author":"Marshall","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.clinthera.2019.04.015_bib30","doi-asserted-by":"crossref","first-page":"e18468","DOI":"10.1371\/journal.pone.0018468","article-title":"Why do women reject bisphosphonates for osteoporosis? A videographic study","volume":"6","author":"Scoville","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.clinthera.2019.04.015_bib31","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1001\/archinternmed.2011.32","article-title":"Effects of benefits and harms on older persons' willingness to take medication for primary cardiovascular prevention","volume":"171","author":"Fried","year":"2011","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2019.04.015_bib32","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1177\/0272989X0202200411","article-title":"Primary prevention drug therapy: can it meet patients' requirements for reduced risk?","volume":"22","author":"Llewellyn-Thomas","year":"2002","journal-title":"Med Decis Making"},{"key":"10.1016\/j.clinthera.2019.04.015_bib33","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.pec.2006.08.004","article-title":"Patient willingness to take teriparatide","volume":"65","author":"Fraenkel","year":"2007","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.clinthera.2019.04.015_bib34","doi-asserted-by":"crossref","first-page":"e116","DOI":"10.1016\/j.clbc.2018.10.008","article-title":"Beliefs about medication and uptake of preventive therapy in women at increased risk of breast cancer: results from a multicenter prospective study","volume":"19","author":"Thorneloe","year":"2019","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.clinthera.2019.04.015_bib35","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3899\/jrheum.130548","article-title":"Patient perceptions of osteoporosis treatment thresholds","volume":"41","author":"Neuner","year":"2014","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.clinthera.2019.04.015_bib36","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/art.40062","article-title":"Brief report: clinical trials aiming to prevent rheumatoid arthritis cannot detect prevention without adequate risk stratification: a trial of methotrexate versus placebo in undifferentiated arthritis as an example","volume":"69","author":"Burgers","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.clinthera.2019.04.015_bib37","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1136\/annrheumdis-2013-205009","article-title":"Improved performance of epidemiologic and genetic risk models for rheumatoid arthritis serologic phenotypes using family history","volume":"74","author":"Sparks","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2019.04.015_bib38","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2017-000479","article-title":"Which patients presenting with arthralgia eventually develop rheumatoid arthritis? The current state of the art","volume":"3","author":"Boeters","year":"2017","journal-title":"RMD Open"},{"key":"10.1016\/j.clinthera.2019.04.015_bib39","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/acr.23510","article-title":"Effectiveness of a web-based personalized rheumatoid arthritis risk tool with or without a health educator for knowledge of rheumatoid arthritis risk factors","volume":"70","author":"Prado","year":"2018","journal-title":"Arthritis Care Res (Hoboken)."},{"key":"10.1016\/j.clinthera.2019.04.015_bib40","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/acr.23411","article-title":"Disclosure of personalized rheumatoid arthritis risk using genetics, biomarkers, and lifestyle factors to motivate health behavior improvements: a randomized controlled trial","volume":"70","author":"Sparks","year":"2018","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.clinthera.2019.04.015_bib41","doi-asserted-by":"crossref","first-page":"i1102","DOI":"10.1136\/bmj.i1102","article-title":"The impact of communicating genetic risks of disease on risk-reducing health behaviour: systematic review with meta-analysis","volume":"352","author":"Hollands","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.clinthera.2019.04.015_bib42","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1017\/S0007114516002488","article-title":"The effect of communicating the genetic risk of cardiometabolic disorders on motivation and actual engagement in preventative lifestyle modification and clinical outcome: a systematic review and meta-analysis of randomised controlled trials","volume":"116","author":"Li","year":"2016","journal-title":"Br J Nutr"},{"key":"10.1016\/j.clinthera.2019.04.015_bib43","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1146\/annurev-genom-092010-110722","article-title":"Communicating genetic risk information for common disorders in the era of genomic medicine","volume":"14","author":"Lautenbach","year":"2013","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"10.1016\/j.clinthera.2019.04.015_bib44","first-page":"167","article-title":"Perceptions of predictive testing for those at risk of developing a chronic inflammatory disease: a meta-synthesis of qualitative studies","volume":"21","author":"Bayliss","year":"2018","journal-title":"J\u00a0Risk Res"},{"key":"10.1016\/j.clinthera.2019.04.015_bib45","first-page":"129","article-title":"Healthcare professionals\u2019 perceptions of risk in the context of genetic testing for the prediction of chronic disease: a qualitative metasynthesis","volume":"21","author":"Falahee","year":"2018","journal-title":"J\u00a0Risk Res"},{"key":"10.1016\/j.clinthera.2019.04.015_bib46","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1093\/rheumatology\/keu159","article-title":"Symptom complexes in patients with seropositive arthralgia and in patients newly diagnosed with rheumatoid arthritis: a qualitative exploration of symptom development","volume":"53","author":"Stack","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clinthera.2019.04.015_bib47","doi-asserted-by":"crossref","unstructured":"van Tuyl LH, Stack RJ, Sloots M, et\u00a0al. Impact of symptoms on daily life in people at risk of rheumatoid arthritis. Musculoskeltal Care.14:169\u2013173.","DOI":"10.1002\/msc.1127"},{"key":"10.1016\/j.clinthera.2019.04.015_bib48","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1007\/s10067-015-3038-3","article-title":"Views on clinically suspect arthralgia: a focus group study","volume":"35","author":"Newsum","year":"2016","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.clinthera.2019.04.015_bib49","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.pec.2018.12.011","article-title":"Effect of communicating personalized rheumatoid arthritis risk on concern for developing RA: a randomized controlled trial","volume":"102","author":"Marshall","year":"2018","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.clinthera.2019.04.015_bib50","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010555","article-title":"Perceptions of risk and predictive testing held by the first-degree relatives of patients with rheumatoid arthritis in England, Austria and Germany: a qualitative study","volume":"6","author":"Stack","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.clinthera.2019.04.015_bib51","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1002\/acr.23179","article-title":"Patients' perceptions of their relatives' risk of developing rheumatoid arthritis and of the potential for risk communication, prediction, and modulation","volume":"69","author":"Falahee","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.clinthera.2019.04.015_bib52","article-title":"I\u00a0would never take preventive medication! Perspectives and information needs of people who underwent predictive tests for rheumatoid arthritis","author":"Mosor","year":"2019","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.clinthera.2019.04.015_bib53","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/jhn.12179","article-title":"A\u00a0systematic review of the factors associated with interest in predictive genetic testing for obesity, type II diabetes and heart disease","volume":"27","author":"Collins","year":"2014","journal-title":"J\u00a0Hum Nutr Diet"},{"key":"10.1016\/j.clinthera.2019.04.015_bib54","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00054725-200606000-00009","article-title":"Do patients with inflammatory bowel disease want genetic testing?","volume":"12","author":"Konda","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.clinthera.2019.04.015_bib55","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1177\/0272989X15600708","article-title":"Does introducing imprecision around probabilities for benefit and harm influence the way people value treatments?","volume":"36","author":"Bansback","year":"2016","journal-title":"Med Decis Making"},{"key":"10.1016\/j.clinthera.2019.04.015_bib56","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMp1608282","article-title":"Uncertainty in the era of precision medicine","volume":"375","author":"Hunter","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clinthera.2019.04.015_bib57","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.jbspin.2013.05.005","article-title":"Primary prevention of rheumatoid arthritis: a qualitative study in a high-risk population","volume":"80","author":"Novotny","year":"2013","journal-title":"Jt Bone Spine"},{"key":"10.1016\/j.clinthera.2019.04.015_bib58","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s41927-018-0026-7","article-title":"Perspectives of patients, first-degree relatives and rheumatologists on preventive treatments for rheumatoid arthritis: a qualitative analysis","volume":"2","author":"Munro","year":"2018","journal-title":"BMC Rheumatol"},{"key":"10.1016\/j.clinthera.2019.04.015_bib59","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s41927-018-0038-3","article-title":"Perceptions of first-degree relatives of patients with rheumatoid arthritis about lifestyle modifications and pharmacological interventions to reduce the risk of rheumatoid arthritis development: a qualitative interview study","volume":"2","author":"Simons","year":"2018","journal-title":"BMC Rheumatol"},{"key":"10.1016\/j.clinthera.2019.04.015_bib60","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/acr.22959","article-title":"Inflammatory arthritis prevalence and health services use in the First Nations and non\u2013First Nations populations of Alberta, Canada","volume":"69","author":"Barnabe","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.clinthera.2019.04.015_bib61","first-page":"983","article-title":"Familial seropositive rheumatoid arthritis in North American Native families: effects of shared epitope and cytokine genotypes","volume":"32","author":"Oen","year":"2005","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.clinthera.2019.04.015_bib62","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11926-016-0598-4","article-title":"Preventive treatments for rheumatoid arthritis: issues regarding patient preferences","volume":"18","author":"Finckh","year":"2016","journal-title":"Curr Rheumatol Rep"},{"issue":"suppl 10","key":"10.1016\/j.clinthera.2019.04.015_bib63","article-title":"Bansback N Preventing rheumatoid arthritis: north American perspectives on the risk of developing the disease and of potential preventative interventions","volume":"69","author":"Harrison","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.clinthera.2019.04.015_bib64","article-title":"Preventing rheumatoid arthritis (pre-RA): preferences of potential recipients, patients and health care professionals for preventive treatment","volume":"45","author":"Harrison","year":"2018","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.clinthera.2019.04.015_bib65","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/(SICI)1099-1050(200003)9:2<109::AID-HEC503>3.0.CO;2-L","article-title":"Sensitivity and perspective in the valuation of health status: whose values count?","volume":"9","author":"De Wit","year":"2000","journal-title":"Health Econ"},{"key":"10.1016\/j.clinthera.2019.04.015_bib66","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2015-000171","article-title":"Psychological factors predict adherence to methotrexate in rheumatoid arthritis; findings from a systematic review of rates, predictors and associations with patient-reported and clinical outcomes","volume":"2","author":"Hope","year":"2016","journal-title":"RMD Open"},{"key":"10.1016\/j.clinthera.2019.04.015_bib67","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2017-000585","article-title":"Predicting adherence to therapy in rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis: a large cross-sectional study","volume":"5","author":"Smolen","year":"2019","journal-title":"RMD Open"},{"key":"10.1016\/j.clinthera.2019.04.015_bib68","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s10198-018-0954-6","article-title":"How well do discrete choice experiments predict health choices? A systematic review and meta-analysis of external validity","volume":"19","author":"Quaife","year":"2018","journal-title":"Eur J Health Econ"},{"key":"10.1016\/j.clinthera.2019.04.015_bib69","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.jval.2017.04.007","article-title":"Testing the external validity of a discrete choice experiment method: an application to latent tuberculosis infection treatment","volume":"20","author":"Mohammadi","year":"2017","journal-title":"Value Health"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291819301791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291819301791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:50:30Z","timestamp":1758963030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291819301791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":69,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0149291819301791"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2019.04.015","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preferences of Patients and At-risk Individuals for Preventive Approaches to Rheumatoid Arthritis","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2019.04.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}